Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Kiri A. Sandler"'
Autor:
Kiri A. Sandler, MD, Darlene Veruttipong, MPH, Vatche G. Agopian, MD, Richard S. Finn, MD, Johnny C. Hong, MD, Fady M. Kaldas, MD, Saeed Sadeghi, MD, Ronald W. Busuttil, MD PhD, Percy Lee, MD
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 4, Pp 237-243 (2016)
Objectives: We report single-institution clinical efficacy and safety outcomes for patients with unresectable locally advanced cholangiocarcinoma who were treated with stereotactic body radiation therapy (SBRT) and a subset of patients who received n
Externí odkaz:
https://doaj.org/article/d41a2279a1c74dc9b1d146d7e7895470
Publikováno v:
International Brazilian Journal of Urology, Vol 45, Iss 1, Pp 23-31
ABSTRACT Objectives: To ascertain the opinions of North American genitourinary (GU) experts regarding inclusion of technologies such as prostate - specific membrane antigen (PSMA) and C – 11 choline positron emission tomography (PET) into routine p
Externí odkaz:
https://doaj.org/article/49d194eab7264ad3adb53c0c93f6dca9
Autor:
Shearwood McClelland III, Kiri A. Sandler, Catherine Degnin, Yiyi Chen, Arthur Y. Hung, Timur Mitin
Publikováno v:
International Brazilian Journal of Urology, Vol 45, Iss 2, Pp 273-287
ABSTRACT Introduction: Several recent randomized clinical trials have evaluated hypofractionated regimens against conventionally fractionated EBRT and shown similar effectiveness with conflicting toxicity results. The current view regarding hypofract
Externí odkaz:
https://doaj.org/article/87b6da9be5fe46129998ea6a9c762783
Autor:
Susan A. McCloskey, Patrick A. Kupelian, Michael L. Steinberg, Kiri A. Sandler, Sandra A. Mitchell, Ann C. Raldow, Ethan Basch, J. Sharif, Ryan Cook
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:44-52
Purpose To improve assessment of symptomatic toxicity in cancer clinical trials and complement clinician-based toxicity reporting, the US National Cancer Institute developed a measurement system called the Patient-Reported Outcomes version of the Com
Autor:
Danny Y. Song, Richard G. Stock, Jeffrey J. Tosoian, Eric A. Klein, Ryan Fiano, Andrew J. Stephenson, William J. Aronson, Ridwan Alam, Christopher R. King, Nicholas G. Nickols, John V. Hegde, Michael L. Steinberg, Jay P. Ciezki, Ryan Cook, Curtiland Deville, Robert E. Reiter, Grace Shaw, Ahmad Sadeghi, Phuoc T. Tran, Chandana A. Reddy, Anthony V. D'Amico, Amar U. Kishan, Sun Mi Yoo, Daniel J. Krauss, Todd McNutt, Eric M. Horwitz, Gregory S. Merrick, Stephen Greco, Eyad Abu-Isa, Talha Shaikh, Wolfgang Lilleby, D. Jeffrey Demanes, Paul L. Nguyen, Trude B. Wedde, Theodore L. DeWeese, Ashley E. Ross, Patrick A. Kupelian, Kiri A. Sandler, Mark Pomerantz, Daniel E. Spratt, Jonathan W. Said
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 101:883-888
Purpose Gleason score (GS) 10 disease is the most aggressive form of clinically localized prostate adenocarcinoma (PCa). The long-term clinical outcomes and overall prognosis of patients presenting with GS 10 PCa are largely unknown because of its ra
Autor:
Isaac Yang, Michael L. Steinberg, Kiri A. Sandler, Percy Lee, Amar U. Kishan, Ryan Cook, Narek Shaverdian, Christopher R. King
Publikováno v:
Cancer. 123:2274-2282
BACKGROUND Published guidelines regarding the optimal treatment strategies for brain metastases focus on patients with ≤3 lesions. As delivery techniques for stereotactic radiosurgery (SRS) improve, radiation oncologists are increasingly using it f
Autor:
Joshua G. Cohen, Gottfried E. Konecny, Mitchell Kamrava, Michael L. Steinberg, Kiri A. Sandler, Shane Mesko
Publikováno v:
International Journal of Gynecologic Cancer. 27:403-408
ObjectivesWe report single-institution clinical outcomes of women treated with stereotactic ablative radiotherapy (SABR) for oligometastatic or progressive gynecological malignancies.Materials and MethodsFrom 2009 to 2015, 47 lesions from 28 patients
Publikováno v:
Clinical Genitourinary Cancer. 16:e543-e545
Three randomized clinical trials have established brachytherapy (BT) boost in combination with external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT) as superior to definitive EBRT and ADT alone in terms of biochemical control
Publikováno v:
Clinical Genitourinary Cancer. 16:e323-e325
Introduction The ProtecT trial has provided level 1 evidence supporting active surveillance for prostate cancer patients with low-risk and intermediate-risk disease. The effect of these findings on the opinions of North American genitourinary (GU) ex
Autor:
Tania Kaprealian, Rogelio Medina, David L. McArthur, Michael T. Selch, Kiri A. Sandler, Daniel C. Lu, Michael L. Steinberg, Percy Lee, Nzhde Agazaryan, Antonio A.F. De Salles, Stephen Tenn, Luke Macyszyn, Mark A. Attiah, Bilwaj Gaonkar, George Farha
Publikováno v:
World neurosurgery. 136
Objective Stereotactic body radiotherapy (SBRT) is an effective treatment of spinal metastases in the vertebral body. However, variation has existed between practitioners regarding the appropriate target delineation. As such, we compared the tumor co